BELLUS Health Inc.
News
GSK completes $2B acquisition of Bellus Health
SeekingAlpha.com: All News GSK (GSK) has formally closed its $2B acquisition of Canadian biotech Bellus Health (BLU). Read more here.\n more…
BELLUS Health (TSX:BLU) Shares Pass Above Fifty Day Moving Average of $19.34
Ticker Report Shares of BELLUS Health Inc. (TSX:BLU Get Rating) passed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of C$19.34 and traded as high as C$19.47. BELLUS Health shares last traded at C$19.46, with a volume of 5,578 shares. Analyst ...\n more…
BELLUS Health (NASDAQ:BLU) Sees Large Volume Increase
Ticker Report Shares of BELLUS Health Inc. (NASDAQ:BLU Get Rating) saw an uptick in trading volume on Wednesday . 2,825,233 shares traded hands during trading, a decline of 9% from the previous sessions volume of 3,099,651 shares.The stock last traded at $14.72 and had previously closed at $14.73. ...\n more…
BELLUS Health Inc. (NASDAQ:BLU) Short Interest Up 6.2% in May
Ticker Report BELLUS Health Inc. (NASDAQ:BLU Get Rating) saw a significant growth in short interest during the month of May. As of May 31st, there was short interest totalling 7,590,000 shares, a growth of 6.2% from the May 15th total of 7,150,000 shares. Based on an average daily volume of 4,610,000 ...\n more…
BTIG Reaffirms Their Hold Rating on BELLUS Health (BLU)
TipRanks Financial Blog In a report released yesterday, Justin Zelin from BTIG reiterated a Hold rating on BELLUS Health (BLU - Research Report). The company's shares clos...\n more…
BELLUS Health (NASDAQ:BLU) Sees Large Volume Increase
Ticker Report BELLUS Health Inc. (NASDAQ:BLU Get Rating) saw unusually-strong trading volume on Thursday . Approximately 6,643,096 shares traded hands during mid-day trading, an increase of 127% from the previous sessions volume of 2,930,878 shares.The stock last traded at $14.45 and had previously...\n more…